noul (376930) Stock Overview

Noul Co., Ltd. engages in the in vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, and immunohistochemistry services. Noul Co., Ltd. was founded in 2015 and is headquartered in Yongin-si, South Korea.